APA (7th ed.) Citation

A, G., G, R., N, P., C, B., MS, D. P., A, D. R., . . . R, F. (2023). Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia. Cancers, 15(9), . https://doi.org/10.3390/cancers15092411

Chicago Style (17th ed.) Citation

A, Guarini, et al. "Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia." Cancers 15, no. 9 (2023). https://doi.org/10.3390/cancers15092411.

MLA (9th ed.) Citation

A, Guarini, et al. "Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia." Cancers, vol. 15, no. 9, 2023, https://doi.org/10.3390/cancers15092411.